Aerobic exercise in muscular dystrophy
Gain without pain One of the first questions patients and families ask when diagnosed with a neuromuscular disorder is "Will exercise help or hurt?" This query is understandable given the multiple historical examples of exercise overcoming weakness and building strength, dating back to Milo of Croton in the 6th century, who practiced the progressive resistance of lifting his growing bull calf, up through more contemporary media proponents as Charles Atlas, Jane Fonda, and Tony Horton in the ubiquitous P90X infomercials. Until recently, however, definitive answers to this query have been elusive, with little hard data on which to base advice. Traditionally, patients with peripheral nerve and muscle disorders were often advised to reduce their physical activity in order to preserve their limited motor function for activities of daily living. Patients with acute radiculopathies, for example, were often admitted to inpatient services for extended bed rest as standard treatment.
Multiple studies supported this concept of overwork injury from resistive (rather than aerobic) exercise, although these conclusions have been based on the effects of intensive exercise regimens 1 or asymmetries between dominant and nondominant limbs, 2 rather than controlled moderate exercise. There is also evidence from a mouse dystrophy model that eccentric exercise, a type of exercise with particular risk for muscle damage, can be more damaging to dystrophic muscle than to normal muscle. 3 However, other evidence shows that moderate exercise can decrease onset of motor deficits compared with minimal and excessive activity in a mouse model of amyotrophic lateral sclerosis, as well as increase motor neuron density in the spinal cord compared with a sedentary control group. 4 In this issue of Neurology ® , Andersen et al. 5 report on the effects of regular moderate aerobic training in patients with genetically proven facioscapulohumeral muscular dystrophy (FSHD) type 1, measuring multiple outcomes before and after 12 weeks of aerobic exercise. They further divided the intervention group to look at the effect of postexercise protein-carbohydrate supplementation compared to a postexercise placebo. The authors randomized 41 patients to 3 weekly 30-minute aerobic exercise sessions on a stationary bike or to a nonintervention control group. Multiple outcomes showed improvement in the exercise group, including fitness as measured by VO 2max (improved 10%) and workload (18%), measured on a bicycle ergometer, as well as the practical measure of walking speed as measured by the 6-minute walk test (7%). No effect was seen from postexercise protein-carbohydrate supplementation compared to placebo. It is an impressive set of results for an intervention lasting just 12 weeks, particularly for a chronic, progressive disorder. Equally notable was the fact that there was no evidence that exercise accelerated muscle damage or increased weakness in these patients. As expected for any exercise program, adherence was an issue; 7 of 26 patients did not complete the entire duration of the planned exercise program.
Several aspects of this study facilitate the ready application of these results to clinical practice. Stationary bicycling is a form of exercise readily available to most patients at home or a local gym. The frequency and duration of the exercise sessions-3 times a week for 15 minutes during the first week, 20 minutes the second week, and 30 minutes thereafter-are a reasonable commitment for a patient. While detailed measurements of VO 2max were utilized in the study to set the aerobic exercise level at 70% of VO 2max , a reasonable approximation of this level of aerobic exercise can be achieved with the simple Talk Test, a greatest level of exertion at which the exerciser can comfortably continue to talk out loud. 6 The use of a pulse watch heart rate monitor gave participants quick feedback to exercise intensity that may also be helpful in an independent setting.
These data provide further evidence that allows clinicians to answer the traditional exercise for muscular dystrophy question with confidence, as this study allows us to give meaningful evidence-based exercise advice to patients with FSHD, the third most common muscular dystrophy. This research group and others have also found positive results with aerobic exercise in other dystrophies, including myotonic dystrophy and Duchenne dystrophy. 7, 8 These studies support a growing body of literature suggesting that clinicians have underemphasized the effectiveness of exercise for patients with many neurologic disorders, not just those in the neuromuscular realm. In addition to the motor benefits of exercise and increased activity, recent articles in Neurology have shown strong association of activity with decreased risk of Alzheimer disease 9 and increased preservation of gray matter volume. 10 Maximizing their function through exercise and activity can allow patients to retain an increased locus of control over their decreased function, which may lead to an overall better sense of wellbeing, as evidenced in the Anderson FSHD study by increased Short Form-36 scores. 5 It would serve patients well to change priorities and make aerobic exercise one of the first interventions to be considered, rather than an afterthought, when developing treatment plans for patients with neurologic disease.
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